Comparison of pirfenidone and corticosteroid treatments at the COVID-19 pneumonia with the guide of artificial intelligence supported thoracic computed tomography.
Murat AcatPinar Yıldız GülhanSerkan OnerMuhammed Kamil TuranPublished in: International journal of clinical practice (2021)
Antifibrotic agents can reduce fibrosis that may develop in the future. These can also help dose reduction and/or non-use strategy for methylprednisolone therapy, which has many side effects. Further large series and randomised controlled studies are needed on this subject.
Keyphrases
- artificial intelligence
- computed tomography
- machine learning
- big data
- pulmonary fibrosis
- coronavirus disease
- deep learning
- sars cov
- idiopathic pulmonary fibrosis
- positron emission tomography
- spinal cord
- high dose
- current status
- magnetic resonance imaging
- study protocol
- case control
- randomized controlled trial
- dual energy
- spinal cord injury
- intensive care unit
- low dose
- respiratory failure
- finite element
- magnetic resonance
- smoking cessation